Portfolio Design Labs, LLC Novartis Ag Transaction History
Portfolio Design Labs, LLC
- $485 Billion
- Q1 2025
A detailed history of Portfolio Design Labs, LLC transactions in Novartis Ag stock. As of the latest transaction made, Portfolio Design Labs, LLC holds 3,139 shares of NVS stock, worth $365,410. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,139
Previous 2,842
10.45%
Holding current value
$365,410
Previous $277 Million
26.53%
% of portfolio
0.07%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,523Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.38 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.21 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$1 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$821 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$787 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $250B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...